PPT-Lessons from meta-analyses of Randomized Clinical Trials fo

Author : alida-meadow | Published Date : 2017-11-29

Andrew Bate Senior Director Epidemiology Group Lead Analytics PSI Conference London 16 May 2017 Acknowledgements and disclosure Presentation is a personal perspective

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Lessons from meta-analyses of Randomized..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Lessons from meta-analyses of Randomized Clinical Trials fo: Transcript

Andrew Bate Senior Director Epidemiology Group Lead Analytics PSI Conference London 16 May 2017 Acknowledgements and disclosure Presentation is a personal perspective but contents are based on a manuscript in development . the statistics right for integrative research involving . Ayurveda. Ashwini Mathur. (Novartis Healthcare Pvt. Ltd, Hyderabad). August 1, 2013, . Samyukti. 2013. 1. Disclaimer/Acknowledgements. All views expressed are authors’ and do not reflect the views of Novartis.. trials. Kinza Waqar. Assisitant. Clinical Research Associate. Shifa. Clinical research Center. (SCRC). Contents:. What are RCTs?. General Principals of RCTs. Randomization: The strength of RCTs. Allocation concealment . Chrissie Fletcher . (. one of two EFPIA representatives on the ICH E9 Working Group). PSI/EFSPI 1-day scientific meeting 28-Sept-15. International Conference on Harmonisation of Technical Requirements. de chimiothérapie dans les cancers des . VADS: actualisation. Jean-Pierre . Pignon. , . Pierre . Blanchard, . Anne . Lee, . Laureen. . Majed. , Sophie . Marguet. , . Claire . Petit, Cécile . Landais. Professor, Stanford University; . Director. , Stanford Prevention Research Center . Evidence-based medicine has been hijacked. Lown Conference, Chicago, 4/2016. John P.A. Ioannidis, MD, DSc. C.F. Rehnborg Chair in Disease Prevention. Director of Research. Royal London Hospital for Integrated Medicine. Member, WHO expert panel on Traditional & Complementary Medicine . Member, Advisory and Editorial Board, Cochrane Collaboration . Susan S. . Ellenberg. , Ph.D.. University of Pennsylvania. SCT/ICTMC Joint Meeting. Liverpool, UK. May 8, 2017. CLINICAL TRIALS TIMELINE. 1948: First randomized clinical trials of modern era. 1962: Amendments to U.S. Food, Drug and Cosmetic Act requiring demonstration of efficacy as well as safety. Overview of Clinical Trials. : Phase I-III. Patricia . Mucci. . LoRusso,. D.O.. Associate Center Director – Innovative Medicine. Yale Cancer Center. <3% of all Cancer Patients Enroll in Clinical Trials. ) - 2012. J. Jack Lee, Ph.D.. Department of Biostatistics. University of Texas . M. D. Anderson Cancer Center. 1: Study Population. Definition of study population. What is population of interest?. Generalization, inference making. CLINICAL TRIALS IN THE TWENTY-FIRST CENTURY: ONGOING CHALLENGES AND EMERGING ISSUES Susan S. Ellenberg , Ph.D. University of Pennsylvania SCT/ICTMC Joint Meeting Liverpool, UK May 8, 2017 CLINICAL TRIALS TIMELINE Susan S. . Ellenberg. , Ph.D.. University of Pennsylvania. SCT/ICTMC Joint Meeting. Liverpool, UK. May 8, 2017. CLINICAL TRIALS TIMELINE. 1948: First randomized clinical trials of modern era. 1962: Amendments to U.S. Food, Drug and Cosmetic Act requiring demonstration of efficacy as well as safety. Lawrence J. Fine, MD, . DrPH. , . FAHA. Division . of Cardiovascular Sciences. NHLBI/NIH. November 16, . 2013. Disclosures: . None. SHAPE Symposium. When I was a glimmer in my parent’s eye the March of Dimes had a mission to eradicate polio . Junjing Lin. [Takeda], Margaret Gamalo [Pfizer], . Ram Tiwari. [BMS]. Expanding Real World Evidence in Pre-market Approvals. What Constitutes Externally Controlled Trials? . Potential Outcomes Framework. Why it Matters, How it Affects Power and How to Generate a Randomization List. Brian . Ronayne. Research Statistician. nQuery. Webinar. Host. Agenda. Randomization in Clinical Trials. Common Randomization Strategies.

Download Document

Here is the link to download the presentation.
"Lessons from meta-analyses of Randomized Clinical Trials fo"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.